Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
1.610
+0.090 (5.92%)
Sep 30, 2025, 4:08 PM HKT
HKG:0460 Revenue
Sihuan Pharmaceutical Holdings Group had revenue of 1.15B CNY in the half year ending June 30, 2025, with 8.57% growth. This brings the company's revenue in the last twelve months to 2.10B, up 19.55% year-over-year. In the year 2024, Sihuan Pharmaceutical Holdings Group had annual revenue of 1.90B with 2.18% growth.
Revenue (ttm)
2.10B CNY
Revenue Growth
+19.55%
P/S Ratio
6.38
Revenue / Employee
786.51K CNY
Employees
2,667
Market Cap
14.67B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.90B | 40.57M | 2.18% |
Dec 31, 2023 | 1.86B | -320.65M | -14.70% |
Dec 31, 2022 | 2.18B | -857.20M | -28.21% |
Dec 31, 2021 | 3.04B | 574.17M | 23.30% |
Dec 31, 2020 | 2.46B | -414.09M | -14.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
WuXi Biologics | 21.98B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |